Overview September, 2018
|
|
- Laurel Sharp
- 5 years ago
- Views:
Transcription
1 Overview September, 2018 A preliminary prospectus (the Prospectus ) containing important information relating to the securities described in this document has been filed with the securities regulatory authorities in each of the provinces and territories of Canada except Québec. A copy of the Prospectus, and any amendment, is required to be delivered with this document. The Prospectus is still subject to completion. There will not any sale or any acceptance of an offer to buy the securities until a receipt for the final prospectus has been issued. This document, dated September 17, 2018, does not provide full disclosure of all material facts relating to the securities offered. Investors should read the Prospectus, the final prospectus and any amendments for disclosure of those facts, especially risk factors relating to the securities offered, before making an investment decision.
2 Disclaimer The presented materials and accompanying oral presentation may constitute forward-looking information within the meaning of Canadian securities laws and are based on expectations, estimates and projections as of the date of this presentation. Forward-looking statements include, without limitation, statements with respect to: a) the completion of the Offering and receipt of all regulatory approvals in connection therewith; b) the use of the net proceeds of the Offering; c) the availability of investment opportunities; d) the performance of the Corporation s business and operations; e) applicable laws, regulations and any amendments thereof including, but not limited to, the legalization of adult use of cannabis and the timing thereto; f) the competitive and business strategies of the Corporation; g) the experience and knowledge of the Corporation and its advisors; h) the Corporation s expectations regarding proposed amendments to its investment strategy and restrictions and the benefits associated with such amendments; i) statements related to the effect and consequences of certain regulatory initiatives; j) the expected growth of the cannabis sector; k) the competitive conditions of the industry; l) the Corporation s investments in the U.S. and consequences of those investments under U.S. federal law; and m) the anticipated changes to laws regarding the recreational use of cannabis and the business impacts on the Corporation s investments. Forward-looking statements are based upon management s perceptions of historical trends, current conditions and expected future developments, as well as a number of specific factors and assumptions that, while considered reasonable by management as of the date on which the statements are made in this presentation, are inherently subject to significant business, economic and competitive uncertainties and contingencies which could result in the forward-looking statements ultimately being incorrect. In addition to the various factors and assumptions set forth in this presentation, the material factors and assumptions used to develop the forward-looking information include, but are not limited to: general economic, financial market, regulatory and political conditions in which the Corporation operates; the Corporation will be able to compete in the industry; the Corporation will be able to make investments on suitable terms; issuers in the Portfolio will be able to meet their objectives and financial estimates and that the risk factors noted below, collectively, do not have a material impact on the Corporation. By its nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. Known and unknown risk factors, many of which are beyond the control of the Corporation could cause actual results to differ materially from the forward-looking information in this presentation. Such factors, without limitation, include the following, (which are discussed in greater detail in the Risk Factors section of the Prospectus and the Risk Factors section of the IPO Prospectus): assurance that the Corporation will be able to achieve its investment objectives; discretion in the use of proceeds; additional financing; risk factors related to dilution; risk factors related to investments in the United States; investments may be pre-revenue; private companies and illiquid securities; limited operating history; there is no guarantee that the amendments to the Corporation s investment restrictions will be approved by Shareholders and implemented by the Corporation; competition; resale of securities; regulatory risks; risks relating to the performance of the Portfolio issuers and the valuation of the portfolio; risks relating to recent and future global financial developments; industry concentration risks; changes to the cannabis laws; United States anti-money laundering laws and regulations; sensitivity to interest rates and currency exposure risks; reliance on the Manager and Investment Manager; conflicts of interest; risks related to dilution; loss of investment; risks relating to foreign market exposure. These risk factors are not intended to represent a complete list of the factors that could affect the Corporation and investors are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking statements. The Corporation disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, or to explain any material difference between subsequent actual events and such forward-looking statements, except to the extent required by applicable law. Terms undefined herein have the meanings ascribed to them in the Prospectus. An investor should rely only on the information contained in the Prospectus. This presentation is qualified in its entirety by reference to, and must be read in conjunction with, the detailed information appearing in the Prospectus. Neither the Corporation nor the Agent have authorized anyone to provide investors with different or additional information. The Corporation is not offering, or soliciting offers to acquire, the securities in any jurisdiction in which the offer is not permitted. For purchasers outside Canada, neither the Corporation nor the Agent have done anything that would permit the offering or distribution of this presentation together with the Prospectus in any jurisdiction where action for that purpose is required, other than in Canada. An investor is required to inform itself about and to observe any restrictions relating to the planned public offering and the distribution of this presentation and of the Prospectus. No securities regulatory authority has expressed an opinion about the securities of the Corporation discussed in this presentation and it is an offence to claim otherwise. The securities of the Corporation discussed in this presentation have not been, and will not be, registered under the U.S. Securities Act, or the securities laws of any state of the United States and, subject to certain exceptions, may not be offered, sold or delivered, directly or indirectly, in the United States except pursuant to an exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws. This presentation does not constitute an offer to sell or solicitation of an offer to buy any of the securities of the Trust in the United States. An investment in the securities offered by the Prospectus must be considered speculative as the securities are subject to certain risk factors as set out under the heading Risk Factors in the Prospectus or IPO process or otherwise described in the Prospectus or IPO Prospectus. An investment in Units of the Corporation is appropriate only for investors who have the capacity to absorb a loss of some or all of their investment. Investors should also review the financial statements incorporated by reference in the Prospectus.
3 Our Value Proposition Creating an Opportunity for Long-term Cannabis Investing with Reduced Risk CGOC s qualified group of advisors have the knowledge and experience to conduct sound research and due diligence before making any investment decision Exposure to publicly traded companies in both Canada and the U.S. Unique exposure to the private U.S. Cannabis sector the future of legalization will drive growth Ability to invest globally and be a first mover in the global emerging markets Ultimately this diversification results in less volatility and ability to invest across the broad spectrum of Cannabis companies from producers to retails, and everything in between cgocorp.com 3
4 The CGOC Team Experienced Leadership and Operational Team Jamie Blundell Director, President & COO Paul Andersen, CPA, CA Director & CFO Bruce Campbell CIO Nick J. Richards Independent Director Brayden Sutton Independent Director John Durfy Independent Director Gary Yeoman Independent Director 25+ years of experience in senior leadership roles, extensive experience with M&A, private equity firms and large corporate divestitures. Mr. Andersen has over 25 years experience as a director and senior officer of numerous public and private companies, and has experience working with Cannabis companies both domestically and internationally. 24+ years of investment management experience and an active cannabis investor since Founder and Portfolio Manager of StoneCastle Investment Management. A go to professional in the space from media such as Bloomberg, The Globe and Mail and Small Cap Power. Practicing tax attorney, adjunct professor of law and legal specialist to the United States cannabis industry, advising businesses and owners throughout the U.S., and is licensed to practice law in California and Colorado. Co-founded and served as EVP for Supreme Pharmaceuticals from and played an instrumental role in the early days of Invictus MD Strategies Corp., Aurora Cannabis Inc. and CannaRoyalty Corp. Throughout his career, Mr. Sutton has played a major role in restructurings, reverse takeovers, IPOs and M&As 25+ years of senior investment and financial management experience. Previously CIO at a hedge fund and prior to that, Managing Director of Global Equities for the Ontario Municipal Employees Retirement System ( OMERS ) from From 2005 to 2011, Mr. Yeoman served as the CEO of Altus Group, and led the company through a sevenyear growth period. Currently Chairman of the board of Golden Leaf Holdings and Executive Chair of ilookabout. cgocorp.com 4
5 Valuation & Performance CGOC: Performance Over Time Historical performance shows CGOC NAV limiting volatility, while growing % $2.75 $2.50 $2.50 $2.66 $2.25 $2.32 $2.27 $2.44 $ % discount (SP vs NAV) $2.00 $1.88 $1.80 $1.75 $1.57 $1.65 $1.50 Jan 26 Jun 1 Jul 3 Aug 13 Sep 4 CGOC NAV CGOC Share Price cgocorp.com 5
6 The Cannabis Industry Opportunity Canada Leading a Unique Value-Creating Opportunity Canadian Market By 2025, Canadian Cannabis market is forecasted to be on par with the size of beer & tobacco today (1) 2018 est. $1.4B (1) 8.6x over 7 years 2025 proj. $12B+ (1) U.S. Market While the current regulatory environment remains challenging, change is happening fast. New research estimates suggest increasing long-term industry potential 2016 $5.9B 9.7x over 11 years 2027 proj. $57B (2) Canada in the Global Market Canadian companies and investors have tremendous opportunities globally, given Canada s current position as a change leader in the global industry Canada leading the world ACMPR legislation becoming a standard framework globally Canadian companies expanding globally: 14 companies expanding across 13 markets Global medical market growth: +21% CAGR (2) (1) Source: Cowen and Company. (2018). Happy Hour Handbook. (2) Source: Arcview cgocorp.com 6
7 The Cannabis Industry Opportunity Investing Across the Whole Ecosystem Multiplies the Potential $12B Canadian Cannabis industry estimate based on base market business models: cultivation and extraction shown below in green (1) The whole ecosystem projected to be reach $23B, after factoring in ancillary services shown below (2) Suppliers Production Seeds, fertilizers, etc. Production equipment, security & infrastructure Software Cultivation Extraction Research and development Analytical equipment & services Consumer Products Retail and Distribution Flower and oil extracts Edibles, tinctures, topicals, infused etc. Delivery Systems (vaporizers, pipes, rolling papers, etc.) Apparel Online / ecommerce Stores, consumption locations Packaging & distribution Business, regulatory, legal, etc. Services Cannabinoid Therapeutics Finance Real Estate Hemp Capital, Buildings, Marketing Pharmaceuticals Nutraceuticals Fiber, seeds, food structuring equipment Traditional Industry CGOC has also invested in (1) Source: Cowen and Company. (2018). Happy Hour Handbook. (2) Source: Deloitte cgocorp.com 7
8 Future Cannabis Industry Catalysts Upcoming Catalysts Further Pushing the Growth of the Sector Canada M&A Supply agreements / retail distribution October 17 = supply / demand imbalance Regulation on extracted products Investment by pharma / alcohol / tobacco companies United States M&A Continued public offerings Additional state legislation Mid-term elections International Supply agreements Medical program adoption Canadian partnerships 8
9 The CGOC Difference The Cannabis Growth Opportunity Corporation Access to the expertise and focus needed to build and grow an international portfolio of public and private investments to minimize downside risk, while participating in the longterm upside A portfolio of Public Cannabis Businesses Diversified to minimize downside Actively managed Global focus ~60% of invested capital A portfolio of Private Cannabis Businesses Unique access Global focus Target month liquidity ~40% of invested capital cgocorp.com 9
10 CGOC Network Effect Creating Value That Results in Proprietary Deal Flow Gain access to private investments Investors Gain access to professionally managed diversified portfolio Gain name exposure to public markets CGOC Gain exposure to more sophisticated institutional shareholders Private Co s Gain strategic advisory from CGOC Partnerships and M&A opportunities Public Co s cgocorp.com 10
11 U.S. Investments CGOC: Your Gateway to the U.S. Cannabis Market Unique access to private U.S. Cannabis investment opportunities Strong industry connections providing proprietary deal flow CGOC Network Effect in full force south of the border Private U.S. Investments 8 investments across 18 states 6 investments across 5 states in pipeline cgocorp.com 11
12 Portfolio Breakdown CGOC Helps Bring Access to Key Investments in Canada, USA and International Markets, Driven by its Private Portfolio Breakdown of Portfolio* Geographical Breakdown of Public and Private Portfolios 4% Public Portfolio 0% Private Portfolio 4% 56% 40% 22% 78% 38% 58% Cash Private Portfolio Public Portfolio *Portfolio breakdown at cost cgocorp.com 12
13 U.S. Cannabis Market Legalization History Overview cgocorp.com 13
14 Public Portfolio Diversified Across Ecosystem Strategy for public portfolio construction is to actively manage and diversify in three ways: by geography, by sub-sector and by company Diversification Strategy Cultivation & Beyond Canopy Growth Hexo Organigram Canntrust Specialty LPs James E Wagner Indiva Charlotte s Web Namaste Retail Focused Solo Cannabis Ravenquest Planet 13 Vertical Integration / Multi-State Green Thumb Industries C21 Sunniva Vivo Cannabis Harvest One Testing and Extraction Valens Groworks Friday Night Cannex Canada and United States cgocorp.com 14
15 Top 10 Public Investments A Diversified Portfolio of Public Companies Focused on Maximizing Long-Term Growth USA // CXXI Acquisitions of vertical operations Canada // WEED Global market leader Canada // NDVA Niche producer with strain experience Canada // HEXO Low Cost High Margin Canada // OGI East Coast leader / internationally expanding USA // SNN Nevada vertical integration and super dispensary Canada // ALZ Canadian Retail USA // SNN Low-cost producer, pharma and production experience Canada // VGW Extraction & testing Canada // VIVO Pharma and Rec Canada cgocorp.com 15
16 Private Portfolio Diversified Portfolio Focused on Mid-Late Stage Pre-IPO s Across the Value Chain, Including U.S./International Investments USA California Medical Cannabis USA Multi-state medical cannabis USA Cannabis extraction Canada & USA Cannabis healthcare technology Canada Medical cannabis producer USA Vertically integrated cannabis company Canada Organic medical cannabis producer Israel Medical cannabis producer Canada & USA Active investments in U.S. cannabis Jamaica Low cost and energy efficient producer Canada Retail, distribution, manufacturing, innovation USA Artisan cannabis chocolate bars Canada & USA Vertical producer focused on wellness *Highlights represent companies that have announced a potential liquidity event this fall 2018 cgocorp.com 16
17 Private Portfolio Successes Private Portfolio Investments Already Producing Valuation Increases Due to Further Funding and Liquidity Events Acquired Raised a subsequent round of funding Now traded publicly Now traded publicly Now traded publicly cgocorp.com 17
18 Coming Up Special Shareholders Meeting Record date September 14, 2018 Meeting date October 15, 2018 Positive Changes Proposed to Corporation Structure Removing the investment restrictions will allow: More flexibility in managing the business Enable more U.S. private investments Why are the U.S. private investments so important? They offer greater upside in the long-term cgocorp.com 18
19 Use of Proceeds Highlights From The CGOC Private Investment Pipeline A number of private pipeline opportunities Focus Medical / recreational & vertically integrated Location UNITED STATES Medical & vertically integrated UNITED STATES Recreational & vertically integrated UNITED STATES Cultivation & Nursery UNITED STATES Software & decision support platform CANADA & UNITED STATES cgocorp.com 19
20 Summary Investment Highlights Portfolio Value NAV continues to trend well Remain undervalued with a -32% discount to NAV Access to Private Company Deal Flow Several U.S. privates in the pipeline Private holding liquidity events Positive Changes to Structure Positive changes to the Corporation structure Will enhance current investment strategies cgocorp.com 20
21 Delivering long-term returns in cannabis investing through public and private diversification
Overview September, 2018
Overview September, 2018 A preliminary prospectus (the Prospectus ) containing important information relating to the securities described in this document has been filed with the securities regulatory
More informationCORPORATE PRESENTATION
CORPORATE PRESENTATION November 2018 Delivering Long-term Success in Cannabis Investing CSE : CGOC cgocorp.com 1 Disclaimer Terms undefined herein have the meanings ascribed to them in the Prospectus.
More informationInitial Public Offering November 24, 2017 CANNABIS GROWTH OPPORTUNITY CORPORATION. Minimum: $5,000,000 of Units. Maximum: $75,000,000 of Units
A copy of this preliminary prospectus has been filed with the securities regulatory authorities in each of the provinces and territories of Canada except Québec but has not yet become final for the purpose
More informationCorporate Presentation
Corporate Presentation April 2018 CSE: CRZ OTCQX: CNNRF INVESTOR PRESENTATION STOCK DISCLAIMERS Forward Looking Information This investor presentation dated March 2018 (the Presentation ) contains forward-looking
More informationCorporate Presentation
Corporate Presentation March 2018 CSE: CRZ OTCQX: CNNRF 0 INVESTOR PRESENTATION STOCK DISCLAIMERS Forward Looking Information This investor presentation dated March 2018 (the Presentation ) contains forward-looking
More informationDISCLAIMER STATEMENTS
January 2019 DISCLAIMER STATEMENTS This presentation relates to an entity that is directly involved in the United States cannabis industry insofar as its business activities include the cultivation, production,
More informationDISCLAIMER STATEMENTS
November 2018 DISCLAIMER STATEMENTS This presentation relates to an entity that is directly involved in the United States cannabis industry insofar as its business activities include the cultivation, production,
More informationCREATING A NORTH AMERICAN CANNABIS POWERHOUSE APRIL 2019
CREATING A NORTH AMERICAN CANNABIS POWERHOUSE APRIL 2019 DISCLAIMER This presentation contains forward-looking information within the meaning of applicable Canadian securities legislation and may also
More informationNOTICE OF ANNUAL and SPECIAL MEETING OF SHAREHOLDERS TO BE HELD ON FEBRUARY 21, 2019 AND MANAGEMENT INFORMATION CIRCULAR
NOTICE OF ANNUAL and SPECIAL MEETING OF SHAREHOLDERS TO BE HELD ON FEBRUARY 21, 2019 AND MANAGEMENT INFORMATION CIRCULAR January 16, 2019 NOTICE OF ANNUAL and SPECIAL MEETING OF SHAREHOLDERS NOTICE IS
More informationINVESTOR PRESENTATION. June 01, 2018 CSE: CALI OTCQB: FNNZF
INVESTOR PRESENTATION June 01, 2018 CSE: CALI OTCQB: FNNZF DISCLAIMER Cautionary Note Regarding Forward-Looking Information These materials include forward-looking statements. Such statements are based
More informationInitial Public Offering January 16, 2018 CANNABIS GROWTH OPPORTUNITY CORPORATION. Minimum: $5,000,000 of Units. Maximum: $75,000,000 of Units
No securities regulatory authority has expressed an opinion about these securities and it is an offence to claim otherwise. This prospectus (the Prospectus ) constitutes a public offering of these securities
More informationFor personal use only
28 September 2016 MMJ TO UNLOCK SIGNIFICANT VALUE WITH LISTING OF CORE CANNABIS BRANDS ON TSX-V Highlights: Strategic spin out of Canadian subsidiary United Greeneries and Swiss subsidiary Satipharm by
More informationInvestor Presentation. TSX Venture (OGI) OTCQX Best Market (OGRMF)
Investor Presentation TSX Venture (OGI) OTCQX Best Market (OGRMF) Disclaimer & Cautionary Statements This document is current as of February 8, 2019, except where otherwise stated. The information contained
More informationInvestor Presentation January CSE ticker: GW
Investor Presentation January 2019 CSE ticker: GW 2 NOTICE TO RECIPIENT This investment is suitable only for sophisticated investors for whom an investment does not constitute a complete investment program,
More informationInvestor Presentation
Investor Presentation 23 January 2019 2019 MMJ Group Holdings Limited ASX: MMJ www.mmjgh.com.au MMJ Group Holdings Limited Global cannabis investment company Corporate Details Portfolio Investment Approach
More informationNurturing Shareholder Growth
JULY 2018 Nurturing Shareholder Growth EMBLEM CORP. TSXV: EMC DISCLAIMER This documentation is a presentation (the Presentation ) of general background information about Emblem Corp s., ( Emblem ) activities
More informationManagement s Discussion and Analysis. For the Year Ended October 31, 2018
Management s Discussion and Analysis For the Year Ended October 31, 2018 January 17, 2019 The following is a Management s Discussion and Analysis ( MD&A ) of the financial condition and results of operations
More informationCorporate Presentation
Corporate Presentation APRIL 2018 OTCQB: AGTK 1 INVESTOR PRESENTATION STOCK DISCLAIMERS Forward Looking Information This investor presentation dated April 2018 (the Presentation ) contains forward-looking
More informationGolden Leaf Reports Fiscal First Quarter 2018 Results
Golden Leaf Reports Fiscal First Quarter 2018 Results Toronto, Ontario May 30, 2018 Golden Leaf Holdings Ltd. ( Golden Leaf or the Company ) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company
More informationDRIVING THE GLOBAL CANNABIS INDUSTRY
DRIVING THE GLOBAL CANNABIS INDUSTRY The 14 th Regional Investments & Capital Markets Conference of the Jamaica Stock Exchange January 2019 FORWARD-LOOKING STATEMENT This presentation contains forward-looking
More informationFor personal use only
12 December 2017 MMJ Expands Canadian Cannabis Footprint via Strategic Investment in Late-Stage ACMPR Applicant Weed Me Inc. Weed Me is a late stage ACMPR applicant based in Canada s most populated province,
More informationDISCLAIMER LIBERTY HEALTH SCIENCES INC. I INVESTORS PRESENTATION 2
DISCLAIMER This documentation is a presentation (the Presentation ) of general background information about Liberty Health Sciences Inc. s ( Liberty Health Sciences ) activities current as of September
More informationIntroduction to Nature s Way Management Group Inc.
Introduction to Nature s Way Management Group Inc. (A majority controlled subsidiary of E-Debit Global Corporation WSHE OTC Markets ) Corporate Back Ground An Introduction to Nature s Way Management Group
More informationDRIVING THE GLOBAL CANNABIS INDUSTRY. February 2019
DRIVING THE GLOBAL CANNABIS INDUSTRY February 2019 FORWARD-LOOKING STATEMENT This presentation contains forward-looking information within the meaning of applicable Canadian securities laws and forward-looking
More informationAccess a New Frontier
Access a New Frontier Investing in marijuana using etfs Horizons Marijuana Life Sciences Index ETF (hmmj) Horizons Emerging Marijuana Growers Index ETF (hmjr) Innovation is our capital. Make it yours.
More informationCORPORATE PRESENTATION CANADA S CANNABIS COMPANY
CORPORATE PRESENTATION CANADA S CANNABIS COMPANY LEGAL DISCLAIMER NOTICE TO RECIPIENT This investment is suitable only for sophisticated investors for whom an investment does not constitute a complete
More informationSIR Royalty Income Fund. Investor Presentation (TSX: SRV.UN) April 2018
SIR Royalty Income Fund Investor Presentation (TSX: SRV.UN) April 2018 0 Caution Concerning Forward-Looking Statements Statements in this presentation, including the information set forth as to the future
More informationDISCLAIMER LIBERTY HEALTH SCIENCES INC. I INVESTORS PRESENTATION 2
DISCLAIMER This documentation is a presentation (the Presentation ) of general background information about Liberty Health Sciences Inc. s ( Liberty Health Sciences ) activities current as of July 7, 2017.
More informationianthus Capital Holdings, Inc. CNSX: IAN OTCQB: ITHUF
ianthus Capital Holdings, Inc. CNSX: IAN OTCQB: ITHUF 2017 Company Overview December 2017 Disclaimer (1 of 2) Cautionary Note Regarding Forward-Looking Information This investor presentation, dated November
More informationInitial Public Offering
Initial Public Offering April 15, 2014 A final prospectus containing important information relating to the securities described in this document has been filed with the securities regulatory authorities
More informationEmergence, Disruption, Convergence FMI / CPA Victoria Chapters Annual Conference May 16, 2018
Emergence, Disruption, Convergence FMI / CPA Victoria Chapters Annual Conference May 16, 2018 INDUSTRY AT A GLANCE 2 Industry Statistics at a Glance 104 269,502 11,058 Licensed ACMPR AHPs Producers * Patients
More informationSIR Royalty Income Fund. Investor Presentation (TSX: SRV.UN) July 2018
SIR Royalty Income Fund Investor Presentation (TSX: SRV.UN) July 2018 0 Caution Concerning Forward-Looking Statements Statements in this presentation, including the information set forth as to the future
More informationI n v e s t o r P r e s e n t a t i o n A c q u i s i t i o n o f C a n n a F a r m s
I n v e s t o r P r e s e n t a t i o n A c q u i s i t i o n o f C a n n a F a r m s July 30, 2018 TSX-V: VIVO OTCQB: ABCCF Disclaimer Certain information included in this presentation, which was prepared
More informationCanopy Growth to Acquire Hiku Brands to Strengthen Retail and Brand Portfolio
Canopy Growth to Acquire Hiku Brands to Strengthen Retail and Brand Portfolio July 10, 2018 SMITHS FALLS, ON & TORONTO Canopy Growth Corporation ( Canopy Growth ) (TSX:WEED) (NYSE:CGC) and Hiku Brands
More informationDRIVING THE GLOBAL CANNABIS INDUSTRY. Bruce Linton Founder, Chairman & Co-CEO November 2018
DRIVING THE GLOBAL CANNABIS INDUSTRY Bruce Linton Founder, Chairman & Co-CEO November 2018 FORWARD-LOOKING STATEMENT This presentation contains forward-looking information within the meaning of applicable
More informationDRIVING THE GLOBAL CANNABIS INDUSTRY. Bruce Linton Chairman, Founder & Co-CEO February 2019
DRIVING THE GLOBAL CANNABIS INDUSTRY Bruce Linton Chairman, Founder & Co-CEO February 2019 FORWARD-LOOKING STATEMENT This presentation contains forward-looking information within the meaning of applicable
More informationPresented by: Eric Paul & Brad Rogers
Improving the Quality of your Life Presented by: Eric Paul & Brad Rogers 1 A focused medical approach to meet the specific needs of the physicians and patients Standardized Products provide us the ability
More informationBUILDING THE FIRST TRUE CANNABIS CPG PLATFORM DIXIE BRANDS INC. INVESTOR PRESENTATION Q CSE: DIXI.U
BUILDING THE FIRST TRUE CANNABIS CPG PLATFORM DIXIE BRANDS INC. INVESTOR PRESENTATION Q4 2018 CSE: DIXI.U!1 Forward-Looking Information Certain statements in this presentation may constitute "forward-looking"
More informationCONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) EMBLEM CORP. FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2018
CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) OF EMBLEM CORP. FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2018 NOTICE OF UNAUDITED CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS
More informationMarijuana Industry Update: History Suggests Pullback May Be About Done
Marijuana Industry Update: History Suggests Pullback May Be About Done February 28, 2018 Vahan Ajamian, CPA, CA, CFA Analyst Update Since Our January 8, 2018, Industry Report In our January 8, 2018, industry
More information( TEST TSX-V) Ultra Sensitive Cannabis Testing
( TEST TSX-V) Ultra Sensitive Cannabis Testing Disclaimer: Forward-Looking Information 2 This presentation contains "forward-looking information" within the meaning of applicable securities legislation.
More informationCANNABIS WHEATON INCOME CORP. MANAGEMENT S DISCUSSION AND ANALYSIS OF FINANCIAL RESULTS FOR THE PERIOD ENDED MARCH 31, Stated in Canadian Funds
CANNABIS WHEATON INCOME CORP. MANAGEMENT S DISCUSSION AND ANALYSIS OF FINANCIAL RESULTS FOR THE PERIOD ENDED MARCH 31, 2018 Stated in Canadian Funds DATE: MAY 30, 2018 For the Period Ended March 31, 2018
More informationEY Insights: Cannabis valuations. October 2018
EY Insights: Cannabis valuations October 2018 Introduction When was the last time a regulatory change stood up an entirely new industry one large enough to transform the Canadian business landscape, while
More informationEmerald Health Therapeutics Reports 1 st Quarter 2018 Financial Results and Provides Corporate Update
Emerald Health Therapeutics Reports 1 st Quarter 2018 Financial Results and Provides Corporate Update Commences commercial production at its Pure Sunfarms Delta 3 joint venture greenhouse operation VICTORIA,
More informationLOON ENERGY CORPORATION AGREES TO AMALGAMATION WITH EMERGING CANNABIS COMPANY
LOON ENERGY CORPORATION AGREES TO AMALGAMATION WITH EMERGING CANNABIS COMPANY Calgary, Alberta: September 17, 2018 Loon Energy Corporation (NEX: LNE.H) ( Loon ) announces that it has entered into an Amalgamation
More informationTrailing PE Forward PE Buy 10 Analysts. 1-Year Return: -5.1% 5-Year Return: 3328%
Last Close 13.71 (CAD) Avg Daily Vol 9.0M 52-Week High 22.00 Trailing PE 41.6 Annual Div -- ROE 7.7% LTG Forecast -- 1-Mo 38.2% 2019 February 21 TORONTO Exchange Market Cap 3.2B 52-Week Low 4.76 Forward
More informationCSE:CRZ 1 OTCQX:CNNRF
CSE:CRZ OTCQX:CNNRF 1 INVESTOR PRESENTATION STOCK DISCLAIMERS Forward Looking Information This investor presentation dated November 2017 (the Presentation ) contains forward-looking information regarding
More informationCSE: VGW OTC: VGWCF CORPORATE PRESENTATION APRIL 2019
CSE: VGW OTC: VGWCF CORPORATE PRESENTATION APRIL 2019 3 NOTICE TO RECIPIENT This investment is suitable only for sophisticated investors for whom an investment does not constitute a complete investment
More informationBLISSCO CANNABIS CORP. MANAGEMENT DISCUSSION AND ANALYSIS Nine Months Ended October 31, 2018
MANAGEMENT DISCUSSION AND ANALYSIS Nine Months Ended 1.1 Date This Management Discussion and Analysis ( MD&A ) of BlissCo Cannabis Corp. (the Company or BlissCo ) has been prepared by management as of
More informationCORPORATE PRESENTATION
CORPORATE PRESENTATION OCTOBER 2018 CSE: CHM OTCQB: CHMJF FORWARD LOOKING STATEMENTS This corporate document contains forward-looking statements and forward-looking information (collectively, forward-looking
More informationInvestor Presentation Q
Investor Presentation Q2 20181 Safe Harbor Statement Forward Looking Statements This presentation includes forward-looking statements within the meaning of the safe harbor provisions of the United States
More informationFidelity Canadian Focused Equity Investment Trust
Fidelity Canadian Focused Equity Investment Trust Semi-Annual Management Report of Fund Performance September 30, 2018 Caution Regarding Forward-looking Statements Certain portions of this report, including,
More informationAssure Holdings, Inc. Corporate Presentation TSXV: IOM. Strictly Private and C dential
Assure Holdings, Inc. Corporate Presentation TSXV: IOM Strictly Private and C dential DISCLAIMER & SAFE HARBOR All statements and figures made in this presentation and in any verbal statement provided
More informationDRIVING THE GLOBAL CANNABIS INDUSTRY. February 2018
DRIVING THE GLOBAL CANNABIS INDUSTRY February 2018 FORWARD-LOOKING STATEMENT This presentation contains forward-looking information within the meaning of applicable Canadian securities laws and forward-looking
More informationSTRATEGIC PARTNERSHIP WITH ALTRIA TO ACCELERATE GROWTH AND INNOVATION
NASDAQ / TSX TICKER CRON STRATEGIC PARTNERSHIP WITH ALTRIA TO ACCELERATE GROWTH AND INNOVATION December 2018 Disclaimers & Cautionary Statements C R O N O S G R O U P INC. This communication contains forward-looking
More informationInvestor Presentation
Investor Presentation June 2018 Forward looking statements In the course of today s meeting, officers of the Corporation may make, in their remarks or in response to questions, and the accompanying materials
More informationInvestor Presentation
Investor Presentation 31 August 2018 2018 MMJ PhytoTech Limited ASX: MMJ www.mmjphytotech.com.au MMJ Global cannabis investment company Listed on the ASX and trades with the code MMJ Circa 16,000 shareholders;
More informationGLOBAL LEADER IN MEDICAL CANNABIS CREATED BY APHRIA AND NUUVERA COMBINATION
GLOBAL LEADER IN MEDICAL CANNABIS CREATED BY APHRIA AND NUUVERA COMBINATION Combination capitalizes on Nuuvera s expansive international footprint, expanding network into Europe, Africa and the Middle
More informationCROWN CAPITAL PARTNERS INC. TSX: CRWN Investor presentation November 2017
CROWN CAPITAL PARTNERS INC. TSX: CRWN Investor presentation November 2017 Forward looking statements This presentation contains certain forward looking statements and certain forward looking information
More informationCannex - CSE: CNNX OTCQX: CNXXF. A Perfect Match.
Cannex - CSE: CNNX OTCQX: CNXXF & A Perfect Match. DISCLAIMER Cautionary Note Regarding Forward-Looking Information This investor presentation dated November 28, 2018 contains certain forward-looking information
More informationAnnual Management Report of Fund Performance
Annual Management Report of Fund Performance As at December 31, 2016 This annual Management Report of Fund Performance contains financial highlights, but does not contain the complete annual financial
More informationNext Edge Private Debt Fund. Next Edge Capital Corp., October 2017
Next Edge Private Debt Fund Next Edge Capital Corp., October 2017 IMPORTANT NOTES The Next Edge Private Debt Fund or the Fund means the Next Edge Private Debt Fund. Capitalized terms not defined in this
More informationAutomotive Finco Corporation
Automotive Finco Corporation Investor Presentation June 2017 1 Forward Looking Information This presentation and the documents incorporated by reference herein contain forward-looking statements and forward-looking
More informationCorporate Presentation November 2017
Investing In High Yield Businesses Around The Globe Corporate Presentation November 2017 Disclaimer This presentation ( Presentation ) is provided on the basis that neither LGC Capital Ltd) (the Company
More informationVILLAGE FARMS INTERNATIONAL REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS/PURE SUNFARMS EXPANDING CANNABIS PRODUCTION AND SALES
FOR IMMEDIATE RELEASE VILLAGE FARMS INTERNATIONAL REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS/PURE SUNFARMS EXPANDING CANNABIS PRODUCTION AND SALES NOT FOR DISTRIBUTION OVER UNITED STATES WIRE SERVICES
More information$200,000,000 (maximum) (maximum 20,000,000 Equity Shares) $10.00 per Equity Share
No securities regulatory authority has expressed an opinion about these securities and it is an offence to claim otherwise. This prospectus constitutes a public offering of these securities only in those
More informationTier One Capital Limited Partnership Management Discussion and Analysis Nine months ended September 30, 2017
Tier One Capital Limited Partnership Management Discussion and Analysis Nine months ended September 30, 2017 Table of Contents Forward-looking Statements... 3 International Financial Reporting Standards...
More informationNext Edge Private Debt Fund! Next Edge Capital Corp., September 2016!
Next Edge Private Debt Fund! Next Edge Capital Corp., September 2016! IMPORTANT NOTES The Next Edge Private Debt Fund or the Fund means the Next Edge Private Debt Fund. Capitalized terms not defined in
More informationTSX:LEAF Investor Presentation December 2017 Top Licensed Producer
TSX:LEAF Investor Presentation December 2017 Top Licensed Producer Price Close (Dec 7, 2017): $15.47 Market Capitalization: $1.5 billion Basic and F.D. Shares: 94.1/101.4 million Forward-Looking Information
More information$200,000,000 (maximum) (maximum 20,000,000 Units) $10.00 per Unit
No securities regulatory authority has expressed an opinion about these securities and it is an offence to claim otherwise. This prospectus constitutes a public offering of these securities only in those
More informationPOCML 4 INC. Management s Discussion and Analysis. (a Capital Pool Corporation) For the Quarter Ended: March 31, Date of Report: May 30, 2018
POCML 4 INC. (a Capital Pool Corporation) Management s Discussion and Analysis For the Quarter Ended: March 31, 2018 Date of Report: May 30, 2018 This management s discussion and analysis of the financial
More informationHorizons Marijuana Life Sciences Index ETF (HMMJ, HMMJ.U:TSX)
Interim Report June 30, 2018 Horizons Marijuana Life Sciences Index ETF (HMMJ, HMMJ.U:TSX) ACTIVE BENCHMARK BETAPRO Innovation is our capital. Make it yours. www.horizonsetfs.com Contents MANAGEMENT REPORT
More information$50,000,003 (maximum) (maximum 4,355,401 Offered Units) $11.48 per Offered Unit
No securities regulatory authority has expressed an opinion about these securities and it is an offence to claim otherwise. This prospectus constitutes a public offering of these securities only in those
More informationNamaste Technologies Inc. Management Discussion and Analysis Three and six months ended February 28, 2018
Namaste Technologies Inc. Management Discussion and Analysis Three and six months ended 1 This Management s Discussion and Analysis ( MD&A ) has been prepared as at and should be read in conjunction with
More informationCHOICE PROPERTIES AND CANADIAN REAL ESTATE INVESTMENT TRUST COMBINE TO FORM CANADA S LARGEST REIT IN A $6.0 BILLION TRANSACTION
CHOICE PROPERTIES AND CANADIAN REAL ESTATE INVESTMENT TRUST COMBINE TO FORM CANADA S LARGEST REIT IN A $6.0 BILLION TRANSACTION Transformational combination creates the preeminent diversified REIT in Canada
More informationGlobal Leader in Medical Cannabis Created by Aphria & Nuuvera Combination. January 29, 2018
Global Leader in Medical Cannabis Created by Aphria & Nuuvera Combination January 29, 2018 Disclaimer This documentation is a presentation (the Presentation ) of general background information about Aphria
More informationC O R P O R A T E P R E S E N T A T I O N APRIL 2018 C$ RQB
C O R P O R A T E P R E S E N T A T I O N APRIL 2018 C$ RQB U$ RVVQF 1IT F O R W A R D L O O K I N G S T A T E M E N T This presentation contains forward-looking statements. These forward-looking statements
More informationImportant Information for Investors and Stockholders
March 1, 2010 Important Information for Investors and Stockholders This presentation does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any
More informationFidelity Concentrated Canadian Equity Investment Trust
Fidelity Concentrated Canadian Equity Investment Trust Annual Management Report of Fund Performance June 30, 2017 Caution Regarding Forward-looking Statements Certain portions of this report, including,
More informationInvestor presentation
A preliminary short form prospectus containing important information relating to the securities described in this document has not yet been filed with the securities regulatory authorities in each of the
More informationBusiness Combination of Skyline Corporation and Champion Homes Creating the Nation s Largest Publicly Traded Factory-Built Housing Company
Business Combination of Skyline Corporation and Champion Homes Creating the Nation s Largest Publicly Traded Factory-Built Housing Company January 25, 2018 Disclaimer Forward-Looking Statements Statements
More informationMulti-Strategy Linear Investments Limited
Multi-Strategy Linear Investments Limited June 2017 Linear Investments Limited Regulated by FCA. Registered in England and Wales No. 07330725 Linear Core Services Established in 2010 and authorised and
More informationInvestor Community Presentation National Bank Financial: Prospering in a Low Return Environment
Investor Community Presentation National Bank Financial: Prospering in a Low Return Environment Louis Vachon, Chairman, NBF Group Kym Anthony, President and CEO, NBF Group Toronto, April 6, 2005 Today
More informationMaximizing Capital. The Power of Investing with Impact. CRC (3/15) Expiration: 3/16
Maximizing Capital The Power of Investing with Impact CRC1137880 (3/15) Expiration: 3/16 What Is Investing with Impact? Morgan Stanley defines Investing with Impact as an approach that aims to generate
More informationEMERALD HEALTH THERAPEUTICS, INC. MANAGEMENT DISCUSSION AND ANALYSIS For the three and nine months ended September 30, 2017
EMERALD HEALTH THERAPEUTICS, INC. MANAGEMENT DISCUSSION AND ANALYSIS For the three and nine months ended September 30, 2017 Dated: November 15, 2017 - 2 - TABLE OF CONTENTS Forward-Looking Statements...
More informationFidelity Canadian Short Term Fixed Income Investment Trust
Fidelity Canadian Short Term Fixed Income Investment Trust Annual Management Report of Fund Performance June 30, 2017 Caution Regarding Forward-looking Statements Certain portions of this report, including,
More informationCorporate Presentation March 2018
Rapidly Creating a Global Cannabis Supplier Corporate Presentation March 2018 Disclaimer This presentation ( Presentation ) is provided on the basis that neither LGC Capital Ltd. ( LGC ) nor its officers,
More informationSelect Income Managed Portfolio Corporate Class. Portfolio Review Third Quarter 2018
Portfolio Review Third Quarter 2018 Q3 Portfolio Review Third Quarter 2018 as at September 30, 2018 Portfolio Performance (Class F) 1 Month 3 Months 6 Months 1 Year 3 Years 5 Years 10 Years Since Inception
More informationAcquisition of Northpoint Commercial Finance A Leading North American Inventory Finance Lender. May 18, 2017
Acquisition of Northpoint Commercial Finance A Leading North American Inventory Finance Lender May 18, 2017 1 Disclaimer & Prospectus Information This presentation has been prepared by Laurentian Bank
More informationCANOPY GROWTH CORPORATION
CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (IN CANADIAN DOLLARS) TABLE OF CONTENTS Condensed interim consolidated statements of financial position... 1 Condensed interim consolidated
More informationBlockchain. Delivered.
CSE: BLK Blockchain. Delivered. Management Presentation Q1 2018 2018 BLOK Technologies Inc. Disclaimer Except for the statements of historical fact, this presentation contains forward-looking information
More informationTSX:LEAF Investor Presentation March 2018
TSX:LEAF Investor Presentation March 2018 Price Close (Mar 16, 2018): $19.34 Market Capitalization: $1.9 billion Basic and F.D. Shares: 99.8/109.6 million Forward-Looking Information This Presentation
More informationAdvantages of the Canadian Public Capital Markets in the Cannabis Space The Canadian Cannabis Ecosystem. May 2018
Advantages of the Canadian Public Capital Markets in the Cannabis Space The Canadian Cannabis Ecosystem May 2018 Why Canada? Legal and regulatory uniformity nationally for cannabis Cannabis legislation
More informationTSX-Venture Exchange: RRL
SUGARBUD CRAFT GROWERS CORP. PROVIDES UPDATE REGARDING MANAGEMENT CHANGES AND ADDITIONS, FUNDING OF CANNABIS OPERATIONS, INSIDER PARTICIPATION IN RIGHTS OFFERING, INVESTMENT IN INNER SPIRIT HOLDINGS LTD.
More informationDDJ CANADIAN HIGH YIELD FUND
This prospectus constitutes a public offering of these securities only in those jurisdictions where they may be lawfully offered for sale and therein only by persons permitted to sell such securities.
More informationHARVEST ENTERPRISES GROUP OF COMPANIES
HARVEST ENTERPRISES GROUP OF COMPANIES MANAGEMENT S DISCUSSION & ANALYSIS FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2018 AND 2017 (Expressed in United States dollars) MD&A of Harvest Enterprises Group
More informationNinepoint UIT Alternative Health Fund
Ninepoint UIT Alternative Health Fund INTERIM MANAGEMENT REPORT OF FUND PERFORMANCE JUNE 30 The interim management report of fund performance is an analysis and explanation that is designed to complement
More informationTHE AURORA STANDARD QUALITY AGILITY INNOVATION EXECUTION EXPANSION. Acquisition of CanniMed Therapeutics. March 2018
THE AURORA STANDARD QUALITY AGILITY INNOVATION EXECUTION EXPANSION Acquisition of CanniMed Therapeutics March 2018 Forward Looking Statements This presentation (the Document ) by Aurora Cannabis Inc. (
More informationInvestor Presentation
Investor Presentation November 2014 Lee D. Rudow President and CEO John J. Zimmer Sr. Vice President of Finance and CFO 1 Safe Harbor Statement This presentation contains forward-looking statements within
More informationORGANIGRAM HOLDINGS INC. $35,003,000 9,860,000 Common Shares
No securities regulatory authority has expressed an opinion about these securities and it is an offence to claim otherwise. This short form prospectus constitutes a public offering of these securities
More information